Ankit Kansagra

2.9k total citations
67 papers, 657 citations indexed

About

Ankit Kansagra is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Ankit Kansagra has authored 67 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 34 papers in Hematology and 13 papers in Molecular Biology. Recurrent topics in Ankit Kansagra's work include Multiple Myeloma Research and Treatments (19 papers), CAR-T cell therapy research (17 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Ankit Kansagra is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), CAR-T cell therapy research (17 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Ankit Kansagra collaborates with scholars based in United States, Spain and France. Ankit Kansagra's co-authors include Mihaela Stefan, Mark R. Litzow, Kandice A. Kapinos, Navneet S. Majhail, Stephanie Farnia, Saurabh Dahiya, Ajeet Gajra, Praveen Ramakrishnan Geethakumari, Taxiarchis Kourelis and Jesús G. Berdeja and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Ankit Kansagra

61 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ankit Kansagra United States 15 361 215 207 120 73 67 657
Benjamin A. Derman United States 13 297 0.8× 280 1.3× 216 1.0× 63 0.5× 101 1.4× 80 636
Adriana Rossi United States 15 394 1.1× 421 2.0× 317 1.5× 83 0.7× 20 0.3× 94 745
Elena Del Ferro Italy 14 277 0.8× 153 0.7× 83 0.4× 120 1.0× 92 1.3× 22 794
Ja Min Byun South Korea 14 177 0.5× 276 1.3× 183 0.9× 77 0.6× 71 1.0× 120 727
Jie Peng China 13 115 0.3× 238 1.1× 156 0.8× 45 0.4× 42 0.6× 53 509
Khaled El‐Shami Israel 13 391 1.1× 36 0.2× 208 1.0× 240 2.0× 72 1.0× 22 913
Itai Levi Israel 16 206 0.6× 400 1.9× 141 0.7× 85 0.7× 77 1.1× 60 844
J. Hense Germany 15 231 0.6× 65 0.3× 74 0.4× 58 0.5× 72 1.0× 56 589
Ahmad Naim United States 15 99 0.3× 322 1.5× 215 1.0× 96 0.8× 45 0.6× 45 781
Basile Chrétien France 11 530 1.5× 51 0.2× 111 0.5× 113 0.9× 23 0.3× 48 921

Countries citing papers authored by Ankit Kansagra

Since Specialization
Citations

This map shows the geographic impact of Ankit Kansagra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankit Kansagra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankit Kansagra more than expected).

Fields of papers citing papers by Ankit Kansagra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankit Kansagra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankit Kansagra. The network helps show where Ankit Kansagra may publish in the future.

Co-authorship network of co-authors of Ankit Kansagra

This figure shows the co-authorship network connecting the top 25 collaborators of Ankit Kansagra. A scholar is included among the top collaborators of Ankit Kansagra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankit Kansagra. Ankit Kansagra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kansagra, Ankit, et al.. (2025). Validation of a Composite Real-World Mortality Variable Among Patients With Hematologic Malignancies Treated in the United States. JCO Clinical Cancer Informatics. 9(9). e2400233–e2400233. 1 indexed citations
2.
3.
Kapinos, Kandice A., et al.. (2023). Cost-Effectiveness Analysis of CAR T-Cell Therapies vs Antibody Drug Conjugates for Patients with Advanced Multiple Myeloma. Cancer Control. 30. 2905560993–2905560993. 15 indexed citations
4.
Gajra, Ajeet, et al.. (2022). Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice. Pharmaceutical Medicine. 36(3). 163–171. 74 indexed citations
5.
Pezzin, Liliana E., et al.. (2022). Prevalence of Race/Ethnicity Reporting in Light Chain (AL) Amyloidosis Clinical Research in the USA. Journal of Racial and Ethnic Health Disparities. 10(2). 644–650. 1 indexed citations
6.
Patel, Hetal, et al.. (2022). HSR22-178: Real World Outcomes of Cancer Patients With SARS-CoV-2 Infection Receiving Monoclonal Antibodies. Journal of the National Comprehensive Cancer Network. 20(3.5). HSR22–178.
7.
Geethakumari, Praveen Ramakrishnan, et al.. (2021). Balancing Quality, Cost, and Access During Delivery of Newer Cellular and Immunotherapy Treatments. Current Hematologic Malignancy Reports. 16(4). 345–356. 37 indexed citations
8.
Zhang, Yifei, et al.. (2021). Belantamab Mafadotin in Patients with Relapsed/Refractory AL Amyloidosis with Myeloma. Blood. 138(Supplement 1). 1670–1670. 2 indexed citations
9.
Ahmed, Sairah, Qiuhong Zhao, Walter Hanel, et al.. (2021). Post‐relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation. Hematological Oncology. 40(1). 49–57. 2 indexed citations
10.
Buadi, Francis K., Martha Q. Lacy, Gabriela Pérez, et al.. (2020). Phase 2 Trial of Pomalidomide, Ixazomib and Dexamethasone in Patients with Multiple Myeloma with Extramedullary Disease or Plasma Cell Leukemia. Blood. 136(Supplement 1). 34–35. 1 indexed citations
11.
Belli, Andrew J., et al.. (2020). Real-World Treatment Patterns and Outcomes of Patients with Functional High-Risk (Early Relapse) Multiple Myeloma. Blood. 136(Supplement 1). 17–18. 1 indexed citations
12.
Bergstrom, Colin P., Saurabh Dahiya, Weina Chen, et al.. (2020). The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement. Leukemia Research. 100. 106480–106480. 10 indexed citations
13.
Kansagra, Ankit, Wilson I. Gonsalves, Morie A. Gertz, et al.. (2018). Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation. 24(10). 2127–2132. 20 indexed citations
14.
Kansagra, Ankit, David J. Inwards, Stephen M. Ansell, et al.. (2017). Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation. Bone Marrow Transplantation. 53(2). 146–154. 13 indexed citations
15.
Yalniz, Fevzi, Mehrdad Hefazi, Kristen McCullough, et al.. (2017). Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 23(9). 1478–1484. 30 indexed citations
16.
Kansagra, Ankit & Mark R. Litzow. (2017). Treatment of Young Adults with Acute Lymphoblastic Leukemia. Current Hematologic Malignancy Reports. 12(3). 187–196. 7 indexed citations
17.
Kansagra, Ankit & Mihaela Stefan. (2016). Preoperative Anemia. Anesthesiology Clinics. 34(1). 127–141. 26 indexed citations
18.
Loh, Kah Poh, Ankit Kansagra, Meng‐Shiou Shieh, et al.. (2016). Predictors of In-Hospital Mortality in Patients With Metastatic Cancer Receiving Specific Critical Care Therapies. Journal of the National Comprehensive Cancer Network. 14(8). 979–987. 13 indexed citations
19.
Wilcox, Susan R., Ankit Kansagra, & Jeremy B. Richards. (2013). Profound Bradycardia With Decreased PEEP. Respiratory Care. 58(11). e138–e143. 2 indexed citations
20.
Karetzky, Monroe, et al.. (2009). THE IMPACT OF OBESITY AS MEASURED AS BODY MASS INDEX ON LUNG VOLUMES IN A MULTIRACIAL POPULATION. CHEST Journal. 136(4). 120S–120S.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin A. Derman Breakdown of academic impact, for papers by Adriana Rossi Breakdown of academic impact, for papers by Elena Del Ferro Breakdown of academic impact, for papers by Ja Min Byun Breakdown of academic impact, for papers by Jie Peng Breakdown of academic impact, for papers by Khaled El‐Shami Breakdown of academic impact, for papers by Itai Levi Breakdown of academic impact, for papers by J. Hense Breakdown of academic impact, for papers by Ahmad Naim Breakdown of academic impact, for papers by Basile Chrétien
Rankless by CCL
2026